147 related articles for article (PubMed ID: 8197967)
21. NT-proANP and BNP in renovascular and in severe and mild essential hypertension.
Mussalo H; Vanninen E; Ikäheimo R; Hartikainen J
Kidney Blood Press Res; 2003; 26(1):34-41. PubMed ID: 12697975
[TBL] [Abstract][Full Text] [Related]
22. Natriuretic peptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
[TBL] [Abstract][Full Text] [Related]
23. N-terminal proatrial natriuretic peptide predicts two-year remodelling in patients with acute transmural myocardial infarction.
Hole T; Hall C; Skaerpe T
Eur Heart J; 2004 Mar; 25(5):416-23. PubMed ID: 15033254
[TBL] [Abstract][Full Text] [Related]
24. N-terminal proatrial natriuretic peptide in primary care: relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease.
Hall C; Ihlen H; Bonarjee V; Dickstein K; Kjekshus J
Int J Cardiol; 2003 Jun; 89(2-3):197-205. PubMed ID: 12767543
[TBL] [Abstract][Full Text] [Related]
25. Effects of thyroid hormone withdrawal on natriuretic peptides during radioactive iodine therapy in female patients with differentiated thyroid cancer.
Stanciu AE; Hurduc AE; Stanciu MM
Scand J Clin Lab Invest; 2016 Dec; 76(8):626-631. PubMed ID: 27666870
[TBL] [Abstract][Full Text] [Related]
26. Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age.
Holmström H; Hall C; Stokke TO; Thaulow E
Scand J Clin Lab Invest; 2000 Apr; 60(2):149-59. PubMed ID: 10817402
[TBL] [Abstract][Full Text] [Related]
27. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
28. Atrial natriuretic peptides in Han Wistar, Sprague-Dawley and spontaneously hypertensive rats.
Crivellente F; Bocchini N; Bonato M; Vandin L; Faustinelli I; Cristofori P
J Appl Toxicol; 2012 Jul; 32(7):521-6. PubMed ID: 22083722
[TBL] [Abstract][Full Text] [Related]
29. Analysis of peptides derived from Pro Atrial Natriuretic Peptide that circulate in man and increase in heart disease.
Macaulay Hunter EF; Kelly PA; Prowse C; Woods RJ; Lowry PJ
Scand J Clin Lab Invest; 1998 May; 58(3):205-16. PubMed ID: 9670344
[TBL] [Abstract][Full Text] [Related]
30. Cocaine increases circulating levels of atrial natriuretic peptide and pro atrial natriuretic peptide N-terminal fragment in conscious rats.
Pelkonen M; Luodonpää M; Vuolteenaho O; Pasanen M; Ruskoaho H
Eur J Pharmacol; 1996 May; 304(1-3):55-62. PubMed ID: 8813584
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of plasma N-terminal proatrial natriuretic peptide (proANP) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarction.
Jernberg T; Stridsberg M; Lindahl B
Am J Cardiol; 2002 Jan; 89(1):64-6. PubMed ID: 11779526
[No Abstract] [Full Text] [Related]
32. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.
Brueckmann M; Huhle G; Lang S; Haase KK; Bertsch T; Weiss C; Kaden JJ; Putensen C; Borggrefe M; Hoffmann U
Circulation; 2005 Jul; 112(4):527-34. PubMed ID: 16027260
[TBL] [Abstract][Full Text] [Related]
33. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.
Gill D; Seidler T; Troughton RW; Yandle TG; Frampton CM; Richards M; Lainchbury JG; Nicholls G
Clin Sci (Lond); 2004 Feb; 106(2):135-9. PubMed ID: 12974669
[TBL] [Abstract][Full Text] [Related]
34. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
Melander O; Frandsen E; Magnusson M; Grubb A; Jovinge S; Groop L
J Intern Med; 2005 Mar; 257(3):281-8. PubMed ID: 15715685
[TBL] [Abstract][Full Text] [Related]
35. Elevated plasma atrial natriuretic peptide concentrations in hypertensive patients with acute myocardial infarction.
Górecki A; Januszewicz A; Opolski G; Lapiński M; Wocial B; Ignatowska-Switalska H; Słomka K; Kochanowski J; Stolarz P
J Cardiovasc Risk; 1995 Feb; 2(1):45-50. PubMed ID: 7606640
[TBL] [Abstract][Full Text] [Related]
36. Concentrations of N-terminal ProANP in human plasma: evidence for ProANP (1-98) as the circulating form.
Buckley MG; Sagnella GA; Markandu ND; Singer DR; MacGregor GA
Clin Chim Acta; 1990 Oct; 191(1-2):1-14. PubMed ID: 2150013
[TBL] [Abstract][Full Text] [Related]
37. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation.
Omland T; Bonarjee VV; Nilsen DW; Sundsfjord JA; Lie RT; Thibault G; Dickstein K
Br Heart J; 1993 Nov; 70(5):409-14. PubMed ID: 8260270
[TBL] [Abstract][Full Text] [Related]
39. B-type natriuretic peptide infusions in acute myocardial infarction.
Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
[TBL] [Abstract][Full Text] [Related]
40. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
Rubattu S; Barbato A; Marchitti S; Iacone R; Di Castro S; Evangelista A; Stanzione R; Ippolito R; Sciarretta S; Palmieri L; Volpe M; Strazzullo P;
J Hypertens; 2010 Aug; 28(8):1638-45. PubMed ID: 20453667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
